Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Hikma halts production of pain drug because of ‘gelatinous particles’ in vials

Hikma’s U.S. operation has stopped production of an injected pain drug as it figures out how to fix an issue that has resulted in black, oily and gelatinous particles in some vials of the drug. The drugmaker made the disclosure as it extended its recall to the retailer and medical facilities.  The voluntary recall of […]

Pfizer adds Coca-Cola, GE vets to board to help navigate post-Upjohn growth

Pfizer and Mylan, nearing the finish line on their planned generics megamerger, have shuffled their leadership teams in anticipation of the new company coming online. After announcing it would move two of its directors into leadership roles at the merger, Pfizer is bringing on two corporate vets to help lead during a period analysts say could be […]

Eli Lilly says its drug supply, including insulins, are safe from COVID-19 for now 

Eli Lilly, one of the major producers of insulin for the U.S., reassured consumers and the market today, saying it does not expect any shortages of its products as the COVID-19 outbreak spreads around the world.   It pointed out that it does not get the active pharmaceutical ingredients for any of its approved medicines from China, […]

Testing lab challenges FDA findings that carcinogens in metformin do not exceed acceptable levels

As questions about suspected carcinogens in drugs continue to roil the supply chain, the FDA last month said its testing of metformin did not find any with unacceptably high levels of NDMA. But testing laboratory Valisure has challenged those findings in a new Public Citizen petition, saying it discovered problems in 42% of the batches […]

Former Sanofi CEO Brandicourt takes board seat at RNAi therapy maker Alnylam

When former Sanofi CEO Olivier Brandicourt handed the reins to Paul Hudson in June, it marked a turning point after a tumultuous period at the French drugmaker. Now eight months out of a job, Brandicourt is now taking a boardroom seat at a much younger drugmaker with the opportunity for big growth in the coming […]

Drugmakers tell analyst ingredient prices are rising as FDA reports first supply hit tied to COVID-19

The world’s heavy reliance on cheap Chinese ingredients has shown a fault line in the U.S., as the FDA reports the first shortage of a drug due to the COVID-19 outbreak. With 20 other FDA approved drugs relying solely on China as the source of an API or finished product, more shortages may soon materialize. […]

Biohaven set to take on Allergan, Lilly with new migraine med and 500-plus reps

With a new FDA nod for migraine medicine Nurtec ODT, Biohaven will be going up against serious marketing muscle from Allergan and Eli Lilly. But the company is optimistic about its rollout thanks to an “unbelievable” label and a sales team of more 500 reps, execs said Friday.  Formerly known as rimegepant, Nurtec ODT is a dissolvable oral medication that offers migraine sufferers “early and sustained efficacy,” Biohaven’s neurology […]

Pfizer, Mylan vets tapped for Viatris board, C-suite as merger nears

With the board appointments of former leaders at Pfizer and Mylan, generics megamerger Viatris has already indicated its predecessors would play an outsized leadership role. Now, with nine more Pfizer and Mylan board members moving over––and a Pfizer CFO, to boot––the past is definitively the future at Viatris.  Viatris has fleshed out its 13-member board of […]

Amarin aims for Vascepa boom with doubled sales force nearly in place

Amarin scored an FDA win with blockbuster potential last year when its fish oil-derivative Vascepa received a heart-helping nod on top of statins. Now, with Amarin’s fleshed out sales force nearly in place and prescriptions soaring, the drugmaker is ready to take Vascepa to the next level.  Amarin closed 2019 with a whopping 87% increase […]

AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik

British drugmaker AstraZeneca has spent much of the past few years in asset-sale mode, offloading of a range of its specialty products in return for extra cash to plow into areas such as oncology. Now, AstraZeneca has agreed to divest the rights to one of its GI meds in a move the acquirer is calling a “transformative event” […]

Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round

It took four tries over four years, but Perrigo has finally gotten over the finish line with its generic of Teva’s tricky-to-make ProAir HFA inhaler for chronic obstructive pulmonary disease and asthma.   Perrigo and its manufacturing partner Catalent touted the news jointly today, saying they are releasing a limited supply now of the generic albuterol […]

Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit

Hamstrung by opioid lawsuits and mounting debt, opioid maker Mallinckrodt has spent the past few months taking a hard look at bankruptcy to help cover its debts. Now, with a massive opioid settlement in the works, Mallinckrodt’s specialty generics business will enter court-supervised restructuring to help secure its hefty payments. Mallinckrodt has agreed to a $1.6 […]